en

PRODUCT DETAIL

Pamifos

Code 99838
MA number 44/0199/06-S
Product Form: con inf 1x20 ml/60 mg (liek.inj.skl.)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Mutual recognition procedure
MAH, country: medac Gesellschaft für klinische Spezialpräparate m.b.H., Germany
Therapeutic Class: 44 - CYTOSTATICA
ATC:
M MUSCULO-SKELETAL SYSTEM
M05 DRUGS FOR TREATMENT OF BONE DISEASES
M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
M05BA Bisphosphonates
M05BA03 Pamidronic acid
Shelf life: 48
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10a well-established use application
MA issued: 11.05.2006
Pediatric warnings: Yes
SPC: SPC_Pamifos_06.2023.pdf  
PIL: PIL_Pamifos_06.2023.pdf  
Dokument: Pamifos_Karta pacienta.pdf  
Safety feature Yes
Data update: 29.05.2019
eu-flag.png sk-flag.png